UFLEX Limited — PPTs, 24-03-2025: Investor Presentation

Financial Performance: In Q3 FY25, UFlex posted revenue of Rs. 37,742 million, reflecting a 12.8% year-over-year increase, fueled by notable growth in packaging films (up 17.9% YoY) and a recovery in the packaging segment (up 15.0% YoY). The normalized EBITDA for the quarter reached Rs. 5,207 million, marking a significant 22.3% YoY increase with an improved margin of 13.8%, aided by better pricing and operational efficiencies. Net profit showed remarkable growth, climbing by 238.6% YoY to Rs. 1,112 million, significantly enhancing the profit margin to 2.9%.

Future Outlook and Growth Drivers: Management remains optimistic about future performance, particularly with ongoing investments in expanding capacity across critical segments, such as aseptic and packaging films. The planned launch of new facilities in Egypt and Mexico is expected to drive growth, capitalizing on increasing demand in those markets.

Order Book and Operational Updates: UFlex continues to build a solid order book, with strong contributions from its Indian operations. The capacity expansion projects, including a new virgin PET chips line in Egypt and debottlenecking at existing plants, further position the company for robust future revenue generation.

Analyst Q&A Insights: Analysts highlighted the significance of international operations in boosting revenue, especially in regions like Nigeria. Management assured them of strategic measures to mitigate foreign currency risks impacting profitability. There are ongoing efforts to navigate increased raw material costs and maintain competitive pricing.

Strategic Focus Areas: Management's strategic initiatives emphasize sustainability and innovation, targeting growth in the eco-friendly packaging sector. Consistent long-term commitments to reduce the carbon footprint align with broader sustainability trends.

Investor Insight: UFlex’s strong financial health and proactive growth strategy suggest potential for a positive investment stance. The notable recovery in profitability alongside new capacity developments presents compelling opportunities, meriting a watchful approach for future investment decisions.